FDA Revokes Emergency Use Authorizations for Three COVID-19 Diagnostic Devices at Manufacturers' Request
July 01, 2026
July 01, 2026
WASHINGTON, July 1 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has revoked three Emergency Use Authorizations for COVID-19 diagnostic devices after manufacturers requested withdrawal of the authorizations.
The notice announces the revocation of Emergency Use Authorizations (EUAs) for Becton, Dickinson and Co.'s BD Veritor System for Rapid Detection of SARS-CoV-2, InBios International Inc.'s SCoV-2 Detect Neutralizing Ab ELISA an . . .
The notice announces the revocation of Emergency Use Authorizations (EUAs) for Becton, Dickinson and Co.'s BD Veritor System for Rapid Detection of SARS-CoV-2, InBios International Inc.'s SCoV-2 Detect Neutralizing Ab ELISA an . . .